HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark T Dransfield Selected Research

fluticasone furoate

1/2022Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial.
6/2021Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial.
4/2021InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
1/2021Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial.
1/2021Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis.
1/2021Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT.
11/2020The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial.
1/2020The effect of exacerbation history on outcomes in the IMPACT trial.
1/2020Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
1/2020Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark T Dransfield Research Topics

Disease

129Chronic Obstructive Pulmonary Disease (COPD)
10/2022 - 08/2004
20Emphysema
10/2022 - 12/2010
13Inflammation (Inflammations)
01/2019 - 08/2013
11Dyspnea (Shortness of Breath)
10/2020 - 11/2011
9Pneumonia (Pneumonitis)
12/2021 - 03/2008
8Asthma (Bronchial Asthma)
12/2021 - 06/2011
8Chronic Bronchitis
03/2016 - 02/2014
4Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 06/2014
3Disease Progression
10/2022 - 12/2013
3Lung Diseases (Lung Disease)
07/2021 - 01/2012
3Obstructive Lung Diseases (Obstructive Lung Disease)
10/2020 - 01/2019
3Infections
01/2020 - 01/2018
2Pulmonary Emphysema
10/2022 - 12/2018
2Weight Loss (Weight Reduction)
12/2021 - 05/2020
2Airway Obstruction (Choking)
10/2021 - 01/2016
2Hypoxia (Hypoxemia)
07/2021 - 12/2018
2Anemia
07/2021 - 05/2020
2Cachexia
05/2020 - 12/2013
2Lung Injury
11/2018 - 02/2014
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 01/2017
2Pulmonary Hypertension
01/2016 - 04/2014
2Cystic Fibrosis (Mucoviscidosis)
01/2016 - 12/2013
2Cough
01/2016 - 04/2015
2Diphtheria
09/2012 - 09/2009
1Lung Neoplasms (Lung Cancer)
11/2022
1Neoplasms (Cancer)
11/2022
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022
1Obesity
12/2021
1Polycythemia (Erythrocytosis)
07/2021
1Chronic Disease (Chronic Diseases)
10/2020
1Fatigue
05/2020
1Anorexia
05/2020
1Cataract (Cataracts)
01/2020
1Frailty
01/2020
1Oral Candidiasis (Thrush)
01/2020

Drug/Important Bio-Agent (IBA)

22GoldIBA
10/2020 - 11/2011
20Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 05/2013
19fluticasone furoateFDA Link
01/2022 - 05/2013
19vilanterolIBA
01/2022 - 05/2013
16Biomarkers (Surrogate Marker)IBA
04/2021 - 07/2009
16Bronchodilator Agents (Bronchodilators)IBA
01/2021 - 08/2004
12GSK573719IBA
01/2022 - 01/2016
10SmokeIBA
01/2020 - 06/2006
8Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2019 - 01/2012
7Oxygen (Dioxygen)IBA
07/2021 - 01/2004
6Metoprolol (Toprol-XL)FDA LinkGeneric
10/2022 - 01/2016
6Azithromycin (Zithromax)FDA LinkGeneric
01/2019 - 08/2011
5Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 06/2014
4SteroidsIBA
01/2022 - 08/2004
4Fibrinogen (Factor I)FDA Link
01/2022 - 01/2016
4RoflumilastIBA
12/2021 - 02/2014
4Fluticasone-Salmeterol Drug Combination (Advair)FDA Link
09/2014 - 08/2004
3Immunoglobulin E (IgE)IBA
12/2020 - 01/2018
3C-Reactive ProteinIBA
05/2020 - 01/2016
3CytokinesIBA
01/2020 - 02/2015
3Proline (L-Proline)FDA Link
11/2019 - 12/2013
3Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2019 - 12/2013
3Biological ProductsIBA
01/2019 - 10/2015
3CollagenIBA
11/2018 - 12/2013
3Proteins (Proteins, Gene)FDA Link
11/2018 - 09/2009
3Brain Natriuretic Peptide (Natrecor)FDA Link
01/2018 - 01/2016
3CalciumIBA
01/2018 - 12/2010
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017 - 06/2011
3ChloridesIBA
02/2014 - 08/2013
3Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
09/2012 - 03/2008
2Angiotensin Receptor AntagonistsIBA
10/2022 - 10/2021
2Losartan (Cozaar)FDA LinkGeneric
10/2022 - 10/2021
2Hemoglobins (Hemoglobin)IBA
07/2021 - 05/2020
2Heme (Haem)IBA
05/2020 - 11/2018
2Environmental Pollutants (Pollutants, Environmental)IBA
01/2020 - 10/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2018 - 06/2014
2Muscarinic AntagonistsIBA
05/2018 - 04/2018
2GlucocorticoidsIBA
05/2018 - 06/2014
2Tiotropium Bromide (Spiriva)FDA Link
04/2018 - 02/2016
2Carbon MonoxideIBA
01/2018 - 07/2013
2ivacaftorIBA
01/2016 - 01/2012
2Superoxides (Superoxide)IBA
02/2015 - 06/2011
2Immunoglobulin G (IgG)IBA
09/2012 - 09/2009
223-valent pneumococcal capsular polysaccharide vaccineIBA
09/2012 - 09/2009
2Polysaccharides (Glycans)IBA
09/2012 - 03/2008
1CadmiumIBA
01/2022
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2021
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2021
1AllergensIBA
12/2020
1IronIBA
05/2020
1icenticaftorIBA
01/2020
1Complement System Proteins (Complement)IBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1BenzodiazepinesIBA
01/2020
1Opioid Analgesics (Opioids)IBA
01/2020
1omega-Chloroacetophenone (Mace)IBA
12/2019

Therapy/Procedure

41Therapeutics
11/2022 - 02/2011
10Nebulizers and Vaporizers (Inhaler)
03/2022 - 04/2018
3Palliative Care (Palliative Therapy)
11/2022 - 01/2019
3Pneumonectomy (Lung Volume Reduction)
01/2020 - 01/2012
3Lung Transplantation
01/2018 - 01/2012
2Patient Readmission
01/2019 - 01/2016
2Length of Stay
01/2018 - 02/2011
2Ambulatory Care (Outpatient Care)
05/2017 - 04/2015
1Glycemic Control
01/2020